TRIC, a Novel Modulator of Intracellular Ca Homeostasis
TRIC, a Novel Modulator of Intracellular Ca Homeostasis
批准号:
8602541
负责人:
Jianjie Ma
金额:
$35.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-15 至 2014-02-28
中文摘要
描述(由申请人提供):细胞信号传导的一个基本方面是钙从肌浆网(SR)或内质网(ER)中隔离的细胞内储存的释放。为了使肌肉细胞的兴奋-收缩耦合或非肌肉细胞的兴奋-分泌耦合有效地运行,反离子穿过SR或ER膜必须伴随着钙的快速流出,以中和钙释放过程中产生的瞬态负电位。虽然有报道称SR或ER膜中存在选择性一价阳离子的通道,但尚未发现编码SR或ER定位阳离子选择性通道的基因。我们最近发现了一个编码三聚体细胞内阳离子选择通道(TRIC)的新基因,该基因在羧基端包含胞内膜保留序列,在氨基端包含保守的亮氨酸拉链基序。纯化后的TRIC蛋白可以在脂质双层膜中形成阳离子选择通道,这为TRIC在钙释放急性期提供反离子运动机制的某些方面提供了可能性。生化研究确定了TRIC和SERCA之间的功能相互作用,这可能会影响SR内的Ca稳态。本项目的重点是定义TRIC的细胞和分子功能,作为调节SR膜对单价阳离子的渗透性的反离子通道和/或作为Ca在SR膜上运输的调节剂。我们将首先利用脂质双分子层重构系统建立TRIC的单通道性质。通过生化和分子分析,我们将确定TRIC的相互作用伙伴,这些伙伴可能参与调节TRIC的通道活性,或调节骨骼肌中TRIC和SERCA之间的功能相互作用。通过对野生型对照和缺乏TRIC的突变肌纤维的比较研究,我们将确定TRIC在介导钙从SR释放的急性期和钙进入SR的活性摄取中的生理作用。由于TRIC代表了一类针对胞内细胞器的新型阳离子通道,了解该蛋白在肌肉生理学中的作用将为我们提供有价值的见解,以调节钙信号在肌肉相关疾病中的作用。以及其他钙调节功能失调导致病理的疾病,如神经退行性疾病。
英文摘要
DESCRIPTION (provided by applicant): A fundamental aspect of cellular signaling is the release of Ca from sequestered intracellular stores in the sarcoplasmic reticulum (SR) or endoplasmic reticulum (ER). For efficient operation of excitation-contraction coupling in muscle cells, or excitation-secretion coupling in non-muscle cells, counter ion movement across the SR or ER membrane must accompany the rapid efflux of Ca to neutralize the transient negative potential produced during Ca release. Although channels selective for monovalent cations have been reported in SR or ER membranes, no gene has been identified that encodes a SR or ER localized cation selective channel. We have recently discovered a novel gene encoding a trimeric intracellular cation-selective channel (TRIC) that contains an intracellular membrane-retention sequence at the carboxyl-terminus and a conserved leucine-zipper motif at the amino-terminus. Purified TRIC protein can form a cation-selective channel in lipid bilayer membrane, providing the possibility that TRIC may provide certain aspects of the counter-ion movement mechanism during the acute phase of Ca release. Biochemical studies identify a functional interaction between TRIC and SERCA, which may influence Ca homeostasis inside the SR. The focus of this project is to define the cellular and molecular functions of TRIC as a counter-ion channel in regulating the permeability of SR membrane to monovalent cations and/or as a modulator of Ca transport across the SR membrane. We will first establish the single channel properties of TRIC using the lipid bilayer reconstitution system. Through biochemical and molecular assays, we will identify the interacting partners for TRIC that may participate in regulating the channel activity of TRIC, or in modulating the functional interaction between TRIC and SERCA in skeletal muscle. Through comparative studies between wild type control and mutant muscle fibers lacking TRIC, we will define the physiological role of TRIC in mediating both the acute phase of Ca release from the SR and active Ca uptake into the SR. As TRIC represents a novel class of cation channels targeted to an intracellular organelle, knowledge of the role of this protein in muscle physiology will provide us valuable insights into the regulation of Ca signaling in muscle-related diseases, and in other diseases where dysfunctional Ca regulation results in pathology, such as neurodegenerative disorders.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Multifaceted role of MG53 in alleviating neuromuscular function decline in ALS
-
批准号:10681888
-
项目类别:
-
资助金额:$67.44万
-
财政年份:2023
-
负责人:Jianjie Ma
-
依托单位:
MG53 function in muscle aging
-
批准号:10442137
-
项目类别:
-
资助金额:$64.9万
-
财政年份:2022
-
负责人:Jianjie Ma
-
依托单位:
MG53 function in muscle aging
-
批准号:10705606
-
项目类别:
-
资助金额:$61.77万
-
财政年份:2022
-
负责人:Jianjie Ma
-
依托单位:
Mitigating neuroinflammation and enhancing neuronal integrity in Alzheimer's disease
-
批准号:10707976
-
项目类别:
-
资助金额:$68.82万
-
财政年份:2022
-
负责人:Jianjie Ma
-
依托单位:
Ca signaling cross-talk from SR to mitochondria in heart muscle
-
批准号:9764466
-
项目类别:
-
资助金额:$65.3万
-
财政年份:2018
-
负责人:Jianjie Ma
-
依托单位:
Myokine function of MG53 in muscle injury-repair and regeneration
-
批准号:9924247
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2017
-
负责人:Jianjie Ma
-
依托单位:
MG53-mediated membrane repair in muscle physiology and disease
-
批准号:9103694
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2016
-
负责人:Jianjie Ma
-
依托单位:
MG53-mediated membrane repair in muscle physiology and disease
-
批准号:9770556
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2016
-
负责人:Jianjie Ma
-
依托单位:
Targeting cell membrane repair for treatment of acute kidney injury
-
批准号:9102545
-
项目类别:
-
资助金额:$54.44万
-
财政年份:2016
-
负责人:Jianjie Ma
-
依托单位:
MG53-Mediated Membrane Repair in Muscle Physiology and Disease
-
批准号:8545523
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2011
-
负责人:Jianjie Ma
-
依托单位:
MG53-Mediated Membrane Repair in Muscle Physiology and Disease
-
批准号:8574275
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2011
-
负责人:Jianjie Ma
-
依托单位:
MG53-Mediated Membrane Repair in Muscle Physiology and Disease
-
批准号:8913669
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2011
-
负责人:Jianjie Ma
-
依托单位:
MG53-Mediated Membrane Repair in Muscle Physiology and Disease
-
批准号:8258363
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2011
-
负责人:Jianjie Ma
-
依托单位:
MG53-Mediated Membrane Repair in Muscle Physiology and Disease
-
批准号:8726719
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2011
-
负责人:Jianjie Ma
-
依托单位:
TRIC, a Novel Modulator of Intracellular Ca Homeostasis
-
批准号:8037642
-
项目类别:
-
资助金额:$42.58万
-
财政年份:2008
-
负责人:Jianjie Ma
-
依托单位:
TRIC, a Novel Modulator of Intracellular Ca Homeostasis
-
批准号:7586164
-
项目类别:
-
资助金额:$42.8万
-
财政年份:2008
-
负责人:Jianjie Ma
-
依托单位:
TRIC, a Novel Modulator of Intracellular Ca Homeostasis
-
批准号:7384601
-
项目类别:
-
资助金额:$43.26万
-
财政年份:2008
-
负责人:Jianjie Ma
-
依托单位:
TRIC, a Novel Modulator of Intracellular Ca Homeostasis
-
批准号:7796559
-
项目类别:
-
资助金额:$43.32万
-
财政年份:2008
-
负责人:Jianjie Ma
-
依托单位:
TRIC, a Novel Modulator of Intracellular Ca Homeostasis
-
批准号:8223258
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2008
-
负责人:Jianjie Ma
-
依托单位:
Ca Sparks in Muscle Aging and Dystrophy
-
批准号:7877944
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2006
-
负责人:Jianjie Ma
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: